RSS Feed – News

  • Emerald Health Pharmaceuticals to Present at Cannabis Invest UK Conference
    Its second, EHP-102, is focused on treating Huntington's disease and Parkinson's disease. The company is completing preclinical development for EHP-101 with the intent to launch a Phase 1 clinical study in 2018. For more information, visit www.emeraldpharma.life or contact: info@emeraldpharma.life. ... read more
    Source: Google NewsPublished on 2018-04-19
  • Huntington’s Disease Epidemiology Market Analysis, Growth Opportunities, Trends, Forecast and …
    Huntington's Disease Epidemiology Market Forecast, 2027” report provides a comprehensive analysis of the Huntington's Disease Epidemiology epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Huntington's Disease Epidemiology  ... read more
    Source: Google NewsPublished on 2018-04-19
  • Opinion: Harry Boxer’s biotech-stock breakouts to watch
    QURE is a gene therapy company focusing on treatments for hemophilia, Huntington's disease and congestive heart failure. Next target: $35. Supernus Pharmaceuticals Inc. SUPN, -0.36% climbed 3%, or $1.70, to close at $48.05 on heavy volume of 923,900 shares traded Wednesday. The move is  ... read more
    Source: Google NewsPublished on 2018-04-19
  • Occupational Therapists showcase their grasp for your grip at Naval Hospital Bremerton
    ... also treat such diagnoses as arthritis, autism, Post-Traumatic Stress Disorder (PTSD), depression, Parkinson's disease, muscular dystrophy, complex regional pain syndrome, multiple sclerosis, cerebral palsy, neuropathy, microcephaly, amyotrophic lateral sclerosis (ALS), and Huntington's disease. ... read more
    Source: Google NewsPublished on 2018-04-19
  • Researchers Use CRISPR to Edit DNA Outside of the Cell for the First Time
    This could be important, he said, for using CRISPR to treat disease. Kmiec noted that while some ailments, like sickle cell anemia and Huntington's disease, involve faulty DNA within a single gene, others, like Alzheimer's and heart disease, appear to involve malfunctions in multiple genes where the  ... read more
    Source: Google NewsPublished on 2018-04-19
  • Huntington’s disease Partnering Research 2018 to 2022
    “Global Huntington's Disease Partnering 2012 to 2018” tracks the major Partnering events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key Partnering players. Along with strategically analyzing the key micro  ... read more
    Source: Google NewsPublished on 2018-04-19
  • ‘You just want someone to love you’: The reality of dating with a terminal illness
    Huntington's, an inherited disease that kills brain cells, is caused by a faulty gene. It can cause jerky movements and trouble walking, speaking and swallowing. Life expectancy is generally about 20 years after the person starts showing symptoms. Mr Hanly's grandfather, the celebrated Auckland painter  ... read more
    Source: Google NewsPublished on 2018-04-19
  • Glycogen in neurons of degenerating brains is beneficial: study
    Using cellular and animal models of Huntington's disease, the researchers have shown that high level of cytotoxic mutant Huntingtin protein triggers more glycogen synthesis in neurons by activating glycogen synthase. They observed that increased level of glycogen synthase protects neurons from the  ... read more
    Source: Google NewsPublished on 2018-04-19
  • H. Lundbeck A/S- (HLUYY) Received Consensus Recommendation of “Hold” from Brokerages
    It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer's disease, Bipolar disorder, depression, epilepsy, Huntington's disease, Parkinson's disease and schizophrenia. Get a free copy of the Zacks research report  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Invasive Brain Monitoring Device Market Share of Top 3 and Top 5 Manufacturers
    Parkinson's Disease. Huntington's Disease. Headache Disorders. Stroke. Others. Invasive Brain Monitoring Device Market Report provides information about supply(Production), consumption, export, import revenue (million USD), market share and growth rate of Invasive Brain Monitoring Device in. ... read more
    Source: Google NewsPublished on 2018-04-18
  • Wireless Brain Sensors Market: Global Top Vendors Product Category, Application and …
    Parkinson's Disease. Huntington's Disease. Migraine. Stroke. Traumatic Brain Injuries. Sleep Disorders. Wireless Brain Sensors Market Report provides information about supply(Production), consumption, export, import revenue (million USD), market share and growth rate of Wireless Brain Sensors in. ... read more
    Source: Google NewsPublished on 2018-04-18
  • Anna Marie Yanny
    Anna Marie Yanny is a graduate of the Behavioral Neuroscience undergraduate program at Western Washington University. Anna Marie believes that by crafting science into a digestible dialogue, we can include everyone in the conversation and find novel solutions. She conducts cognitive  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Exciting Experiments in “Open Science” by Huntington’s Researchers
    Drs Rachel Harding and Tam Maiuri are taking a leap of faith to make discoveries in Huntington's Disease (HD) research swift and open to all. They are publishing their lab notes on fundamental HD research online in real time, at the risk of losing credit for their work. As a ... read more
    Source: Google NewsPublished on 2018-04-18
  • MIT Drug-Discovery Spinout ReviveMed Raises $1.5M
    A group of researchers led by Leila Pirhaji, founder and CEO of ReviveMed and former postdoc at the Massachusetts Institute of Technology, published proof of concept for the company's technology in August 2016 in Nature Medicine, using Huntington's disease as a model. "Metabolomics data provide  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Sussex Healthcare: Celebrating 25 Years of Care
    Sussex Healthcare has several facilities that can provide care for individuals with neurological and acquired brain-injury issues. A wide variety of conditions can be handled by the staff of Sussex Healthcare, including Huntington's disease, multiple sclerosis, motor neurone disease, Parkinson's disease,  ... read more
    Source: Google NewsPublished on 2018-04-18
  • H. Lundbeck A/S (HLUYY) Analysts See $0.81 EPS; NEXTSOURCE MATERIALS CAN (NSRCF …
    The firm offers pharmaceutical products for the treatment of Alzheimer's disease, depression, Parkinson's disease, Schizophrenia, alcohol dependence, anxiety, Bipolar I disorder, Epilepsy, Huntington's disease, and symptomatic neurogenic orthostatic hypotension. Among 2 analysts covering H. ... read more
    Source: Google NewsPublished on 2018-04-18
  • Global Huntington’s Disease Epidemiology and Patient Flow Analysis 2017-2026 …
    The research provides estimates and forecasts of Huntington's Disease prevalence, Huntington's Disease diagnosis rate, and Huntington's Disease treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Europe Huntington’s Disease Epidemiology and Patient Flow Analysis 2017-2026 …
    The research provides insights into Huntington's Disease epidemiology, Huntington's Disease diagnosed patients, and Huntington's Disease treatment rate for EU5 countries. The research measures key indicators including prevalence of Huntington's Disease derived from epidemiological analysis,  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Global Huntington’s Disease Epidemiology and Patient Flow Analysis 2018: Patient Flow …
    The research study helps executives estimate Huntington's Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Criteria for Expedited Handling of Retirement Applications
    Huntington's disease. End-stage sclerops. End-stage Parkinson's disease. End-stage renal disease which cannot receive dialysis or transplantation. Quadriplegia with life-threatening complications. While none of us would wish to have one of these life shortening diseases, it's good to know that OPM  ... read more
    Source: Google NewsPublished on 2018-04-18
  • H. Lundbeck A/S- (HLUYY) Rating Grow to Strong-Purchase at Zacks Investment Research
    According to Zacks, “H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals across the world. Its products are targeted at disorders like depression and anxiety, schizophrenia, insomnia, Huntington's,  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Europe Huntington’s Disease Epidemiology and Patient Flow Report 2018
    The researcher announced the results of its Huntington's Disease patients study in a new research Europe Huntington's Disease Epidemiology and Patient Flow Analysis - 2018'. The research provides insights into Huntington's Disease epidemiology, Huntington's Disease diagnosed patients, and  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Exploring Spark Therapeutics’ Product Pipeline
    It's also developing candidates for neurodegenerative diseases such as Batten disease and Huntington's disease. The company has received an orphan drug designation for its SPK-TPP1 candidate for treating CLN2 disease in the United States. Additionally, Spark Therapeutics entered into a licensing  ... read more
    Source: Google NewsPublished on 2018-04-18
  • UW research investigates Huntington’s disease: Mouse models point to mitochondrial iron as factor
    While medications exist to lessen some of the movement and psychiatric symptoms of Huntington's disease, there are currently no treatments to halt the disease's progression. About 30,000 people in the United States are living with Huntington's disease, according to the National Institutes of Health. ... read more
    Source: Google NewsPublished on 2018-04-18
  • Global Wireless Brain Sensors Market Outlook 2018-2023 : EMOTIV, Advanced Brain Monitoring …
    The study includes a profound summary of the key sectors and the segments Epilepsy , Dementia , Parkinson’s Disease , Huntington's Disease , Migraine , Stroke , Traumatic Brain Injuries , Sleep Disorders of the Wireless Brain Sensors market. Both quickly and slowly growing sectors of the  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Huntington’s Disease Therapeutics Market to witness astonishing growth of 29.46 %
    A new independent 72 page research with title 'Global Huntington's Disease Therapeutics Market 2014-2018' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like Americas, APAC, EMEA and important players/vendors such  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Balmoral runners’ care centre fundraising milestone
    ... facility, launched a £3.9million appeal last June to extend that support to 55 patients. The organisation provides round-the-clock care for those with a range of complex conditions, including motor neurone disease, acquired brain injury, Huntington's disease, Parkinson's disease and multiple sclerosis. ... read more
    Source: Google NewsPublished on 2018-04-18
  • Check the potential misuse of stem cell therapy
    ... cure all diseases involving tissue degeneration, including heart failure, spinal cord injury (actor Christopher “Superman” Reeves was a big supporter of stem cell research), stroke, burns, type 1 diabetes, osteoarthritis, rheumatoid arthritis, muscular dystrophy, Parkinson's disease, Huntington's disease,  ... read more
    Source: Google NewsPublished on 2018-04-18
  • Trevor Garlick urges Dee View Court support in advance of Run Balmoral
    The organisation provides round-the-clock care for those with a range of complex conditions, including motor neurone disease, acquired brain injury, Huntington's disease, Parkinson's disease and multiple sclerosis. It has already raised more than half of its target, but former BP regional president,  ... read more
    Source: Google NewsPublished on 2018-04-18
  • In deep water: Coodanup man catches vandal after spotting something fishy going on
    Mr Wright is on a disability pension for a genetic neurodegenerative disorder, commonly known as Huntington's disease. This was really my place for stress management. I had a routine and now he's killed my routine. I'm stressed and traumatised. Rathmines Street resident Barry Wright. He said it took  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Tolley seeks public view on life choice
    Must have a terminal illness with a prognosis that it will end your life within the next six months, or; Suffer a grievous and irremediable condition, such as a degenerative disease like Huntington's Disease, at an advanced state of decline that is irreversible. The person must be experiencing unbearable  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Huntington’s Disease Therapeutics Market Growth Analysis and Conclusion from 2017 to 2021
    Huntington's Disease Therapeutics Market report is carefully designed to help new entrants and the old players in the Huntington's Disease Therapeutics market to achieve their business and product goals. It will also be helpful to key executive (CEO and COO), potential investors, manufactures, strategy  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Replacing Alcohol With Marijuana May Prevent Dementia
    Patients suffering from this progressive (and fatal) brain deterioration are often diagnosed with Alzheimer's disease, Parkinson's, Huntington's disease and a list of others. There are 10 million new cases of dementia worldwide every year, according to the World Health Organization. The most common  ... read more
    Source: Google NewsPublished on 2018-04-17
  • $0.81 EPS Expected for H. Lundbeck A/S (HLUYY); Drive Shack (DS) Shorts Raised By 4.13%
    The firm offers pharmaceutical products for the treatment of Alzheimer's disease, depression, Parkinson's disease, Schizophrenia, alcohol dependence, anxiety, Bipolar I disorder, Epilepsy, Huntington's disease, and symptomatic neurogenic orthostatic hypotension. Newcastle Investment Corp. operates  ... read more
    Source: Google NewsPublished on 2018-04-17
  • So why not a Marijuana plantation in Boracay?
    The National Organisation for the Reform of Marijuana Laws wrote that “CBD lacks the consciousness-altering properties and abuse potential” of THC and argued there was evidence of “numerous medically beneficial properties” for people diagnosed with Parkinson's disease, Huntington's disease,  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Presentations at the 2018 American Academy of Neurology Highlight the Broad Potential of …
    Sidney Carter Award in Child Neurology: 'Spinal Muscular Atrophy is a Treatable Neurodegenerative Disease'; Presidential plenary session, oral presentation on Sunday, April 22, 10:45 a.m.-11:15 a.m.; 'Open Label Extension of the Phase 3 Study NEURO-TTR to Assess the Long-term Efficacy and  ... read more
    Source: Google NewsPublished on 2018-04-17
  • #AAN2018 – IONIS-HTTRx Shows Promise in Phase 1/2 Trial to Treat Early-stage Huntington’s
    The investigative therapy IONIS-HTTRx effectively reduced levels of the protein responsible for Huntington's disease in early-stage patients, according to the findings of an ongoing Phase 1/2 clinical trial. The results also revealed that IONIS-HTTRx is generally safe and well-tolerated by patients, further  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Wave Life Sciences to Present Data on ALS and FTD Programs and on Huntington’s Disease at the …
    Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, will present key data on its amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) programs and on Huntington's  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Wave Life Sciences to Present Data on ALS and FTD Programs and on Huntington’s Disease at the …
    CAMBRIDGE, Mass., April 17, 2018 (GLOBE NEWSWIRE) --. Wave Life Sciences Ltd. (NASDAQ:WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, will present key data on its amyotrophic lateral sclerosis (ALS) and  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Teva to Present New Data Across Multiple Therapeutic Areas at 70
    The breadth of data spans a diverse set of patient populations including migraine, multiple sclerosis, tardive dyskinesia and Huntington's disease. ... “Teva's data at AAN embodies our expertise in researching and developing highly complex treatments for CNS disorders, especially those for which there  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Teva to Present New Data Across Multiple Therapeutic Areas at 70th Annual Meeting of the …
    Teva will also present AUSTEDO® (deutetrabenazine) tablets data providing clinical and real-world insights into the applicability of use across chorea associated with Huntington's disease and tardive dyskinesia in adults, two often underserved and overlooked movement disorders. The full set of  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Huntington’s Disease Therapeutics Market to Grow at a CAGR of 14.75%, Capacity, Price and …
    Huntington's Disease Therapeutics Market report covers the present scenario and the growth prospects of the Huntington's Disease Therapeutics Market for 2017-2021. The report provides a basic overview of the Huntington's Disease Therapeutics Market including definitions, classifications,  ... read more
    Source: Google NewsPublished on 2018-04-17
  • UI neuroscience researchers share new treatments, unexpected discoveries at faculty TED talks
    To laypersons, it might not seem obvious to search for the evolutionary origins of human intelligence in the genetics of Huntington's disease, or why doctors would want to test novel treatments for the cognitive symptoms of Parkinson's disease by measuring the reflex speeds of lab mice. But University of  ... read more
    Source: Google NewsPublished on 2018-04-17
  • Ohio’s First Medical Marijuana Doctors Address Stigmas, Changing Rules in Ohio
    “A lot of patients that have other forms of anxiety disorders feel that cannabis has been helpful for that. And I do believe there's some research to support that. Certainly other states that have medical marijuana laws have a more inclusive list of diagnoses.” Miller adds that Huntington's disease – ... read more
    Source: Google NewsPublished on 2018-04-17
  • Sparkle in the Dark funds support families dealing with Huntington’s Disease
    SPARKLING UP LIVES: Huntington's Tasmania President Pam Cummings is thrilled that the Ulverstone Rotary Club is fundraising for her charity. Picture: Cordell ... Mrs Cummings said she wanted everyone to be aware of Huntington's Disease and that the NW Coast had the highest rates in the country. ... read more
    Source: Google NewsPublished on 2018-04-17
  • What’s happening Tuesday in the north valley
    North Valley Chapter of California Women for Agriculture: 6:30 p.m. Meets at alternating restaurants or member homes. email northvalleycwa@gmail.com. Third Tuesday. Huntington's Disease Support Group: 6:30 p.m. Help, sharing, education. Enloe Regional Cancer Center library, 265 Cohasset Road. ... read more
    Source: Google NewsPublished on 2018-04-16
  • Sensitive determination of dopamine levels via surface-enhanced Raman scattering of Ag …
    Additionally, the level of DA is highly related with some important neurologic diseases such as schizophrenia, Parkinson, and Huntington's diseases, etc. In light of the important roles that DA plays in the disease modulation, it is of considerable significance to develop a sensitive and reproducible  ... read more
    Source: Google NewsPublished on 2018-04-16
  • Pennsylvania patients will be able to buy dry leaf medical marijuana this summer
    The approved changes also will permit people with any terminal illnesses, neurodegenerative diseases and spinal cord damage to use medical marijuana. The original qualifying conditions were Lou Gehrig's disease, autism, cancer, Crohn's disease, epilepsy, glaucoma, HIV/AIDS, Huntington's disease  ... read more
    Source: Google NewsPublished on 2018-04-16
  • Large aggregates of ALS-causing protein might actually help brain cells
    Large, often fibril-type protein aggregates are in fact the most obvious pathological features of Alzheimer's disease, Parkinson's disease, Huntington's disease, ALS, and other major neurodegenerative diseases. Many of the candidate drugs developed in recent years were designed to clear these protein  ... read more
    Source: Google NewsPublished on 2018-04-16
  • UW in the News
    Medical Xpress, Genetic Engineering and Biotechnology News, and Science News republished UW's release reporting that UW researchers have found that mice engineered to have Huntington's disease have an over-accumulation of iron in their mitochondria. Read UW's original release here. ... read more
    Source: Google NewsPublished on 2018-04-16